ESC 365 - Prasugrel-based de-escalation vs. conventional therapy after percutaneous coronary intervention in ACS patients according to the renal function

ESC Professional Premium Access

Prasugrel-based de-escalation vs. conventional therapy after percutaneous coronary intervention in ACS patients according to the renal function

Session: Late-Breaking Science

Topic: Treatment

Speaker: Doctor H. Kim (Seoul, KR)

Event: ESC Asia 2022 with APSC & AFC

Congress Presentation

About the speaker

Doctor Hyo-Soo Kim

Seoul National University Hospital, Seoul (Korea (Republic of))

5 presentations

0 follower

2 more presentations in this session

The efficacy and safety of pulsed-field ablation in para-Hisian paroxysmal supraventricular tachycardia: first-in-human pilot trial

Speaker: Doctor F. Li (Chengdu, CN)

Multicenter registry of the Watchman left atrial appendage closure device for patients with atrial fibrillation in Japan: The TERMINATOR registry

Speaker: Doctor T. Matsumoto (Kamakura, JP)

Access the full session

Late-Breaking Science

Speakers: Doctor H. Kim, Doctor F. Li, Doctor T. Matsumoto

About the event

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022

Sessions Presentations

Congress

ESC 365 is supported by